| 19 December 2016 | M1 muscarinic allosteric modulators slow prion neurodegeneration and restore memory loss
| Bradley, SJ; Bourgognon, J-M; Sanger, HE; et al. |
| 16 January 2018 | MAFA missense mutation causes familial insulinomatosis and diabetes mellitus
| Iacovazzo, D; Flanagan, S; Walker, E; et al. |
| 16 January 2018 | MAFA missense mutation causes familial insulinomatosis and diabetes mellitus
| Iacovazzo, D; Flanagan, S; Walker, E; et al. |
| 1 March 2017 | Major histocompatibility complex class II (MHCII) and its transcriptional regulator, CIITA, are aberrantly expressed in discrete beta cells in individuals with Type 1 diabetes
| Russell, MA; Foulis, AK; Krogvold, L; et al. |
| 8 April 2020 | Making connections: Social identification with new treatment groups for lifestyle management of severe obesity
| Khan, SS; Tarrant, M; Kos, K; et al. |
| 11 January 2018 | Making new genetic diagnoses with old data: iterative reanalysis and reporting from genome-wide data in 1,133 families with developmental disorders.
| Wright, CF; McRae, JF; Clayton, S; et al. |
| 24 October 2018 | Making the Case for “Whole System” Approaches Integrating Public Health and Housing
| Sharpe, R; Taylor, T; Fleming, L; et al. |
| 12 February 2016 | MALDI-TOF mass spectrometry discriminates known species and marine environmental isolates of Pseudoalteromonas
| Emami, K; Nelson, A; Hack, E; et al. |
| 1 October 2020 | Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial
| Rangan, A; Brealey, SD; Keding, A; et al. |
| 13 June 2017 | Management of sulfonylurea treated monogenic diabetes in pregnancy: implications of placental Glibenclamide transfer
| Shepherd, M; Brook, AJ; Chakera, AJ; et al. |
| 1 May 2018 | Managing with learning disability and diabetes: OK-Diabetes – A case-finding study and feasibility randomised controlled trial
| House, A; Bryant, L; Russell, AM; et al. |
| 2016 | Manual Development and Pilot Randomised Controlled Trial of Mindfulness-based Cognitive Therapy versus Usual Care for Parents with a History of Depression
| Ukoumunne, OC; Mann, J; Kuyken, W; et al. |
| 3 August 2016 | Mapping epigenetic changes to the host cell genome induced by Burkholderia pseudomallei reveals pathogen-specific and pathogen-generic signatures of infection
| Cizmeci, D; Dempster, EL; Champion, OL; et al. |
| 6 September 2020 | Mapping epilepsy-specific patient-reported outcome measures for children to a proposed core outcome set for childhood epilepsy
| Crudgington, H; Collingwood, A; Bray, L; et al. |
| 2 June 2020 | Mapping post-diagnostic dementia care in England: an e-survey
| Frost, R; Walters, K; Wilcock, J; et al. |
| 3 April 2019 | Mapping the autistic advantage from the accounts of adults diagnosed with autism: A qualitative study
| Russell, G; Kapp, SK; Elliott, D; et al. |
| 29 July 2020 | Mapping UK mental health services for adults with attention-deficit/hyperactivity disorder: national survey with comparison of reporting between three stakeholder groups
| Price, A; Janssens, A; Newlove-Delgado, T; et al. |
| 28 July 2015 | Marine Biota and Psychological Well-Being: A Preliminary Examination of Dose-Response Effects in an Aquarium Setting.
| Cracknell, D; White, MP; Pahl, S; et al. |
| 9 November 2017 | Marked intrafamilial variability of exocrine and endocrine pancreatic phenotypes due to a splice site mutation in GATA6
| Savova, R; De Franco, E; Shaw-Smith, C; et al. |
| 4 August 2015 | Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
| Jones, AG; McDonald, TJ; Shields, BM; et al. |
